Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment-Reference-Cited by-同舟云学术

Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment

Published:2021 Issue:15 Volume:13 Page:7108-7118
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Qin Jingbo¹²³⁴⁵,Gong Ningqiang⁶⁷⁸⁹⁵,Liao Zhihuan¹²³⁴⁵,Zhang Shouwen¹⁰¹¹¹²⁵,Timashev Peter¹³¹⁴¹⁵¹⁶¹⁷^ORCID,Huo Shuaidong¹²³⁴⁵^ORCID,Liang Xing-Jie¹²³⁴⁵^ORCID

Affiliation:

1. Fujian Provincial Key Laboratory of Innovative Drug Target Research

2. School of Pharmaceutical Sciences

3. Xiamen University

4. Xiamen 361102

5. China

6. CAS Center for Excellence in Nanoscience

7. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety

8. National Center for Nanoscience and Technology

9. Beijing 100190

10. Neurophysiology Department

11. Beijing ChaoYang Emergency Medical Center

12. Beijing 100122

13. Laboratory of Clinical Smart Nanotechnologies

14. Institute for Regenerative Medicine

15. Sechenov University

16. Moscow 119991

17. Russia

Abstract

This review summarizes the state of the art design and construction of nanosystems used for mitochondria-targeted delivery.

Funder

National Natural Science Foundation of China

Deutsche Forschungsgemeinschaft

National Key Research and Development Program of China

Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety

Xiamen University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2021/NR/D1NR01068A

Reference104 articles.

1. Mitochondrial form and function

2. Mitochondrial Function, Biology, and Role in Disease

3. Mitochondrial metabolism and cancer

4. Nanoformulated ABT-199 to effectively target Bcl-2 at mitochondrial membrane alleviates airway inflammation by inducing apoptosis

5. Mitochondria and Cancer

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-10

2. Optoelectronic tuning of two-dimensional engineered nanomaterials for enhanced photothermal therapy: opportunities and challenges;Graphene and 2D Materials;2024-05-29

3. Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy;Journal of Medicinal Chemistry;2024-04-13

4. Single‐Atom Cu Nanozyme‐Loaded Bone Scaffolds for Ferroptosis‐Synergized Mild Photothermal Therapy in Osteosarcoma Treatment;Advanced Healthcare Materials;2024-03-09

5. Photodynamic Therapy Induced Mitochondrial Targeting Strategies for Cancer Treatment: Emerging Trends and Insights;Molecular Pharmaceutics;2024-02-23